Affimed Therapeutics

NASDAQ-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies.

Launch date

2000

Employees

Market cap

Enterprise valuation

CAD54m (Public information from Sep 2024)

Company register number HRB 721206 (Mannheim)

Heidelberg Baden-Württemberg (HQ)

http://affimed.com

https://twitter.com/affimity https://www.linkedin.com/company/affimed-ag

View job openings

Authorizing premium user...